文献速递银屑病与炎症性皮肤病

CARD14功能获得性突变单独足以驱动体内IL-23/IL-17介导的银屑病样皮肤炎症

CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo.
PubMed 文献 · J Invest Dermatol · 2018-04-22

研究利用携带Card14ΔE138功能获得性突变的杂合小鼠,发现其自发出现慢性银屑病样表型,包括鳞屑性皮损、表皮增厚、角化过度和免疫细胞浸润,且IL-23/IL-17轴驱动发病,中和IL-23p19可显著减轻皮损及抗菌肽和促炎因子表达。

要点

  • Card14ΔE138杂合小鼠自发慢性银屑病样皮损、表皮增厚和免疫浸润。
  • 皮损高表达抗菌肽、趋化因子和Th17型细胞因子,浸润中性粒细胞、髓系细胞和T细胞。
  • 中和IL-23p19可显著减轻皮损及抗菌肽和促炎细胞因子表达。

核心结论

  • CARD14过度活化单独足以在体内驱动Th17介导的银屑病皮肤病的复杂免疫发病机制。

研究设计与样本

  • 研究采用携带CARD14功能获得性突变(Card14ΔE138)的杂合小鼠进行体内实验。

主要发现

  • Card14ΔE138杂合小鼠自发出现慢性银屑病样表型,表现为鳞屑性皮损、表皮增厚、角质形成细胞过度增殖、角化过度和免疫细胞浸润。
  • 受累皮肤高表达抗菌肽、趋化因子和细胞因子(包括Th17细胞特征性细胞因子),并富含中性粒细胞、髓系细胞和T细胞浸润。
  • 疾病发病由IL-23/IL-17轴驱动,中和IL-23p19可显著减轻皮肤病变及抗菌肽和促炎细胞因子表达。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rare autosomal dominant mutations in the gene encoding the keratinocyte signaling molecule CARD14, have been associated with an increased susceptibility to psoriasis, but the physiological impact of CARD14 gain-of-function mutations remains to be fully determined in vivo. Here, we report that heterozygous mice harboring a CARD14 gain-of-function mutation (Card14ΔE138) spontaneously develop a chronic psoriatic phenotype with characteristic scaling skin lesions, epidermal thickening, keratinocyte hyperproliferation, hyperkeratosis, and immune cell infiltration. Affected skin of these mice is characterized by elevated expression of anti-microbial peptides, chemokines, and cytokines (including T helper type 17 cell-signature cytokines) and an immune infiltrate rich in neutrophils, myeloid cells, and T cells, reminiscent of human psoriatic skin. Disease pathogenesis was driven by the IL-23/IL-17 axis, and neutralization of IL-23p19, the key cytokine in maintaining T helper type 17 cell polarization, significantly reduced skin lesions and the expression of antimicrobial peptides and proinflammatory cytokines. Therefore, hyperactivation of CARD14 alone is sufficient to orchestrate the complex immunopathogenesis that drives T helper type 17-mediated psoriasis skin disease in vivo.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Mellett M, Meier B, Mohanan D, et al. CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo. J Invest Dermatol. 2018. PMID: 29689250. doi:10.1016/j.jid.2018.03.1525

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。